NCT00189566View on ClinicalTrials.gov

Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse

PHASE2CompletedINTERVENTIONAL

Enrollment

165

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

April 30, 2009

Conditions

Ovarian CancerFallopian Tube CancerMalignant Tumor of Peritoneum

Interventions

DRUG

Paclitaxel

DRUG

Topotecan

DRUG

Carboplatin

Trial Locations (1)

75004

Hôpital Hotel Dieu, Paris

All Listed Sponsors

lead

ARCAGY/ GINECO GROUP

OTHER

NCT00189566 - Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse | Biotech Hunter | Biotech Hunter